-
Company Insights
Innovation and Patenting activity of GCC SAB de CV Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of GCC SAB de CV Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Sector Analysis
Gulf Cooperation Council (GCC) Destination Tourism Market Insights, Foreign Direct Investment, Source Markets and Opportunities, 2023 Update
Gulf Cooperating Council (GCC) Destination Tourism Insight Report Overview The Gulf Cooperation Council (GCC) is a regional political and economic union comprised of six member states Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates that account for a substantial portion of global crude oil production. The total number of international arrivals in GCC amounted to 49.08 million in 2022. The region garnered a total inbound expenditure of $66.06 billion in 2022. The GCC collectively represents one of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CT-080 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CT-080 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CT-080 in Colorectal Cancer Drug Details: CT-080 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CT-080 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CT-080 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CT-080 in Gastric Cancer Drug Details: CT-080 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CT-080 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CT-080 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CT-080 in Solid Tumor Drug Details: CT-080 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CT-080 in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CT-080 in Esophageal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CT-080 in Esophageal Cancer Drug Details: CT-080 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CT-080 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CT-080 in Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CT-080 in Colorectal Cancer Drug Details: CT-080 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CT-080 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CT-080 in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CT-080 in Gastric Cancer Drug Details: CT-080 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CT-080 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CT-080 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CT-080 in Solid Tumor Drug Details: CT-080 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CT-080 in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CT-080 in Esophageal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CT-080 in Esophageal Cancer Drug Details: CT-080 is under development for the...